Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHPL-49 in Acute Ischemic Stroke Within 8 Hours of Onset
CTR20234035Phase 2Completed
- Sponsor
- Shanghai Hutchison Pharmaceuticals Limited
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SHPL-49 in ischemic stroke, sponsored by Shanghai Hutchison Pharmaceuticals Limited. Started Dec 2023; status: completed.
02
Drugs
SHPL-49
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20234035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20234035.